Vaxcyte (PCVX) PT Set at $120 at Cantor Fitzgerald - Pressure on Shares Explained by Challenging Market

October 12, 2026 7:10 AM

Cantor Fitzgerald analyst Carter Gould set the price target on Vaxcyte (NASDAQ: PCVX) to $120.00 from NA while maintaining an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found